Program


The program will cover topics of biology, routine clinical applications, and future perspectives of cell-free DNA.

Preliminary program >> Click here

PRELIMINARY SCIENTIFIC PROGRAM

DAY 1

8.00 – REGISTRATION

8.25 – OPENING by Frederik Banch Clausen

8.30 – INTRODUCTION
Obstetric and Immunological Background
Dr. Morten H Dziegiel (Copenhagen, Denmark)
The Genetics of Blood Groups – Recent Findings and Current Challenges
Professor Martin L Olsson (Lund, Sweden)
Noninvasive Typing of Fetal Antigens
Professor Ellen van der Schoot
(Amsterdam, The Netherlands)

9.45 – Coffee Break

10.00 – FETAL RHD GENOTYPING I
Technical Aspects of Noninvasive Fetal RHD Genotyping with Real-Time PCR
Professor Dr. Tobias J Legler (Göttingen, Germany)
Clinical Experience with First Trimester Fetal RHD screening and Targeted Prophylaxis in Sweden
Dr. Eleonor Tiblad (Stockholm, Sweden)

10.55 – Coffee Break

11.10 – FETAL RHD GENOTYPING II
Noninvasive Fetal RHD Genotyping in England
Dr. Kirstin Finning (Bristol, England)
Clinical Perspectives from USA on Fetal RHD Genotyping
Professor Ossie Geifman-Holtzman (Philadelphia, USA)

12.00 – Lunch Break

13.00 – BIOLOGY AND IMMUNOLOGY
Microchimerism in Space and over Time: Our Interstellar Movie
Professor J Lee Nelson (Seattle, USA)
From Nine Usable Loci to Surveying the Genomic Landscape of Blood Cell Formation;
60 Years of Blood Cell Genomics
Professor Willem H Ouwehand (England)
Fetal DNA and Preeclampsia
Dr. Peter Celec (Bratislava, Slovakia)

14.30 – Coffee Break

15.00 – InTRODUCTION TO NIPT
New Developments in Noninvasive Prenatal Testing by Plasma DNA Sequencing
Professor Dennis Lo (Hong Kong, China)

19.00 – CONFERENCE DINNER

DAY 2

9.00 – NIPT for GENE disorders and Chromosome abnormalities
Implementation of Cell-Free DNA Testing for Aneuploidy and Monogenic Disorders
Professor Lyn Chitty (London, England)

10.20 – Coffee Break

10.45 – NIPT session continued
Implementation of Whole Genome NIPT for Aneuploidies in Nijmegen
Dr. Brigitte Faas (Nijmegen, The Netherlands)
Microarray-Based Cell-Free DNA Analysis for Aneuploidy Risk Assessment
Dr. Thomas J Musci, CMO Ariosa (San Francisco, USA)

11.45 – Main sponsor talk
Illumina

12.00 – Lunch Break

13.00 – GENOME EDITING
Identifying Candidates for Genome Editing
Dr. Klaus Rieneck (Copenhagen, Denmark)
Applications of CRISPR-Cas9 for Genome Perturbation
Dr. David Scott (Cambridge, USA)

13.50 – Coffee Break

14.15 – Future Applications of Cell-Free DNA
Plasma DNA Sequencing in Cancer and Autoimmune Disease
Professor Dennis Lo (Hong Kong, China)

15.10 – Coffee Break

15.30 – ORAL PRESENTATIONS
A. The first year experiences of routine fetal RHD screening
in Finland Katri Haimila (Finland)
B. Non-invasive prenatal testing of HPA*1A in Poland Agnieszka Orzinska (Poland)
C. Cell-free DNA analysis in maternal plasma for the detection of unbalanced chromosomal abnormalities other than main aneuploidies or microdeletionnel syndromes: a feasibilty study Pascale Kleinfinger (France)
D. Non-invasive prenatal diagnosis (NIPD) of Duchenne and Becker muscular dystrophies (DMD/BMD) by relative haplotype dosage Michael Parks (England)
E. Towards affordable NIPT - Low coverage whole genome resequencing based NIPT on small benchtop NGS systems Micheaela Hýblová (Slovakia)
F. Noninvasive prenatal detection of selected fetal aneuploidies using targeted sequencing of homologs
Taylor Jensen (USA)

17.00 – CONFERENCE ENDS

 




The Meeting Planners
Lyngby Hovedgade 44, 1
2800 Kgs. Lyngby, Denmark
Phone: +45 5060 7420
Email